The use of the recombinant influenza vaccine can prevent a substantial number of influenza-related hospitalizations among ...

We came across a bullish thesis on Bio-Techne Corporation (TECH) on scuttleblurb’s Substack. In this article, we will ...

Orion announces agreement with Shilpa Medicare for Recombinant Human Albumin for European market ...

Researchers at Moscow’s Sechenov University, in collaboration with the Medical University of Vienna, have developed a ...

Hyderabad: Shilpa Medicare Limited, a pharmaceutical and biotechnology company, has announced that its 100 percent subsidiary ...

Huonslab announced the successful completion of patient enrollment in its pivotal phase 1 clinical trial of Hydizyme.

In recent years, overweight and obesity have become a serious global health problem, posing significant risk factors for ...

Shilpa Biocare Private Limited has entered into a strategic partnership with Orion Corporation out-licensing its flagship ...

Researchers have identified C5aR1 as a novel biomarker for metastasis risk and poor prognosis in patients with cutaneous ...

The EC has granted approval for the new subcutaneous (SC) formulation of Bristol Myers Squibb’s (BMS) Opdivo (nivolumab) ...

Orion enters agreement with Shilpa Medicare to commercialise recombinant human albumin in European market: Espoo, Finland Monday, May 26, 2025, 11:00 Hrs [IST] Orion Corporation, ...